Clinical Trials

212 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03854903 2025-02-06

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Phase 1 Completed

19 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02311998 2023-07-17

Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML

Phase 1/2 Completed

22 enrolled 14 charts

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02810990 2023-02-03

BEST

65 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04006847 2022-07-01

Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Phase 1/2 Terminated

1 enrolled 5 charts

GenitourinaryGynecologicOther solid neoplasmThoracic

Leukemia, Myeloid, Chronic-Phase

NCT03023319 2022-06-14

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Phase 1 Completed

6 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Mesothelioma, Ovarian Neoplasms, Thymoma, Thymus Neoplasms

NCT04655391 2022-06-09

Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation

Phase 1 Withdrawn

Leukemia, Myeloid, Acute

NCT02782403 2020-11-19

Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia

Phase 1 Terminated

4 enrolled

Blast Crisis, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT02638467 2020-11-05

Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy

2 enrolled

Bronchiolitis Obliterans Syndrome, Leukemia

NCT02906696 2020-05-11

Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure

Phase 2 Terminated

8 enrolled 14 charts

Leukemia, Myeloid, Chronic-Phase

NCT03205267 2017-07-02

BODO

Phase 2 Unknown

127 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01331291 2016-07-25

Bosutinib in Adult Patients With Recurrent Glioblastoma